Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
BROOMFIELD, CO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it will be presenting at the upcoming Virtual Investor Summit on August 20 th , 2024. Investors may request a one-on-one meeting with management by registering here: .
2024年8月15日科羅拉多州布魯姆菲爾德(GLOBE NEWSWIRE)——醫療保健科技公司Aclarion,Inc.(「Aclarion」或「公司」)(納斯達克:ACON,ACONW)利用生物標誌物和專有的增強智能算法幫助醫生確定慢性下腰痛的位置。(在2024年8月20日即將舉行的虛擬投資者峯會上,宣佈將進行演示。投資者可以通過在此處註冊來請求與管理層的一對一會議。) .
Event: Q3 Investor Summit
Date: August 20, 2024
Presentation Time: 4:00 PM ET
Location:
活動:Q3投資者峯會
日期:2024年8月20日
演示時間:美國東部時間下午4:00
地點:
About Aclarion, Inc.
關於Aclarion, Inc.
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit .
Aclarion是一家醫療保健科技公司,利用磁共振光譜(「MRS」),專有的信號處理技術,生物標誌物和增強智能算法來優化臨床治療。該公司首先通過Nociscan解決慢性下腰痛市場,Nociscan是第一個有證據支持的SaaS平台,可非侵入性地幫助醫生區分腰椎椎間盤疼痛和非疼痛性椎間盤。通過雲連接,Nociscan從每個評估的腰部椎間盤的MRI機器中接收磁共振光譜(MRS)數據。在雲中,專有的信號處理技術提取和量化與盤痛相關的化學生物標誌物。將生物標誌物數據輸入專有算法中,以指示盤可能是疼痛源。當與其他診斷工具一起使用時,Nociscan爲醫生提供有關患者下背痛位置的關鍵洞察力,使醫生可以優化治療策略。欲了解更多信息,請訪問: .
Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
投資者聯繫人:查看更多信息前往:
Kirin m. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com
媒體聯繫人:
Jodi Lamberti
SPRIG諮詢公司
612.812.7477
jodi@sprigconsulting.com